secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001193125-24-061842
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ARS Pharma discloses $228M cash; neffy investor day presentation published
--------------------------------------------------------------------------

- Cash and short-term investments of ~$228M as of December 31, 2023.
- Updated corporate presentation for neffy (epinephrine nasal spray) shared with investors.
- No additional financial results or forward guidance provided in the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312524061842/0001193125-24-061842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312524061842/d809686d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-061842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer